Context The role of positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA) in the primary staging for patients with prostate …

The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

Prostate cancer is the most common cancer diagnosis in men in the United States and a
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …

Context Prostate-specific membrane antigen (PSMA) is a promising molecular target for
prostate cancer (PCa) that has allowed the development of a novel diagnostic approach to …

Background In the initial staging of patients with high-risk prostate cancer (PCa), prostate-
specific membrane antigen positron emission tomography (PSMA-PET) has been …

Importance Prostate-specific membrane antigen (PSMA) positron emission
tomography/computed tomography (PET/CT) can detect low-volume, nonlocalized (ie …

Objectives To investigate whether patients with suspected pelvic lymph node metastases
(molecular imaging [mi] N1) on staging prostate‐specific membrane antigen (PSMA) …

Objectives To investigate the association between intraprostatic, intratumoral maximum
standardised uptake values (SUVmax) on prostate‐specific membrane antigen (PSMA) …

Objective To investigate characteristics and outcomes of oligometastatic hormone‐sensitive
prostate cancer (mHSPC) patients undergoing metastases‐directed therapy (MDT) with …

The aim of this retrospective study was to identify clinical predictors of early biochemical
recurrence (BCR) in patients with high-risk prostate cancer (PCa) treated with carbon-ion …